| Date Filed | Type | Description |
| 10/05/2023 |
4
| HighCape Capital, LLC (10% Owner) has filed a Form 4 on ELUTIA INC.|
Txns:
| Bought 2,837,128 shares
@ $0
Bought 4,255,693 warrants
@ $1.4275, valued at
$6.1M
|
|
| 10/05/2023 |
4
| HighCape Capital, L.P. (10% Owner) has filed a Form 4 on ELUTIA INC.|
Txns:
| Bought 2,837,128 shares
@ $0
Bought 4,255,693 warrants
@ $1.4275, valued at
$6.1M
|
|
| 10/05/2023 |
3
| Elutia PIPE Investment, LP (10% Owner) has filed a Form 3 on ELUTIA INC. |
| 06/12/2023 |
4
| HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 37,500 options to buy
@ $2.37, valued at
$88.9k
Granted 25,000 options to buy
@ $2.37, valued at
$59.3k
|
|
| 06/12/2023 |
4
| Makes Brigid (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.37, valued at
$59.3k
|
|
| 06/12/2023 |
4
| Colpman David (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.37, valued at
$59.3k
|
|
| 06/12/2023 |
4
| Jordan Maybelle (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.37, valued at
$59.3k
|
|
| 04/28/2023 |
4
| Mills C Randal (PRESIDENT AND CEO) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 134,840 restricted stock units
@ $0
Exercised 44,947 restricted stock units
@ $0
Granted 89,894 restricted stock units
@ $0 |
|
| 03/27/2023 |
4
| Birchview Capital, LP (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Bought 100,000 shares
@ $1.491, valued at
$149.1k
Bought 10,000 shares
@ $1.491, valued at
$14.9k
Bought 18,000 shares
@ $1.3539, valued at
$24.4k
Bought 2,000 shares
@ $1.3539, valued at
$2.7k
Bought 10,000 shares
@ $1.587, valued at
$15.9k
|
|
| 03/09/2023 |
4
| Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Sold 289 shares
@ $4.3, valued at
$1.2k
Exercised 937 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Ferguson Matthew (CFO) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Exercised 1,287 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/28/2022 |
4
| HighCape Partners GP II, LLC (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 17,533 options to buy
@ $3.8, valued at
$66.6k
|
|
| 12/27/2022 |
4
| HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 17,533 options to buy
@ $3.8, valued at
$66.6k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
3
| HighCape Partners GP II, LLC (10% Owner) has filed a Form 3 on AZIYO BIOLOGICS, INC. |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/12/2022 |
4
| Ferguson Matthew (CFO) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Paid exercise price by delivering 4,798 shares
@ $7.3, valued at
$35k
Exercised 13,874 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Edwards Peter G (GENERAL COUNSEL) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Paid exercise price by delivering 1,127 shares
@ $7.3, valued at
$8.2k
Exercised 4,625 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Paid exercise price by delivering 4,728 shares
@ $7.3, valued at
$34.5k
Exercised 15,390 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Riebman Jerome (CHIEF MEDICAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Paid exercise price by delivering 5,104 shares
@ $7.3, valued at
$37.3k
Exercised 14,758 restricted stock units
@ $0 |
|
| 08/29/2022 |
3
| Williams Michelle LeRoux (Chief Scientific Officer) has filed a Form 3 on AZIYO BIOLOGICS, INC. |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Jordan Maybelle (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 22,090 options to buy
@ $6.28, valued at
$138.7k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Sold 276 shares
@ $0
Granted 31,000 options to buy
@ $5.08, valued at
$157.5k
Granted 8,700 restricted stock units
@ $0
Exercised 938 restricted stock units
@ $0
Granted 15,390 restricted stock units
@ $0 |
|
|